Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit
27 Noviembre 2023 - 7:00AM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in a fireside
chat and host virtual 1x1 investor meetings at the JMP Securities
Hematology and Oncology Summit.
JMP Securities Hematology and Oncology
SummitFireside Chat: Tuesday, December 5, 2023 at 1:30 pm
ET Location: Virtual
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Vor Biopharma (NASDAQ:VOR)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
